Sobi® (STO: SOBI) today announced that new research showing the effect of emapalumab in patients with macrophage activation syndrome (MAS) in Still's disease, including systemic juvenile idiopathic ...
In an Instagram post titled, 'Ageing secrets I refuse to gatekeep as a 40-year-old dermatologist', dermatologist Dr Shereene Idriss from the US ( @shereeneidriss on Instagram), listed all of the ...
Bill Sibold, Chief Executive Officer of Madrigal, stated, “This will be the first AASLD Liver Meeting following the approval of Rezdiffra earlier this year, and the entire NASH community feels ...